Enteral supplementation of bovine lactoferrin improves gut barrier function in rats after massive bowel resection

British Journal of Nutrition

Volumn 112, Issue 4, 2014, Pages 486-492

  Wu, Jiang ^a,b,c   Chen, Jie ^c,d   Wu, Wenjie ^c,d   Shi, Jia ^c,d   Zhong, Yan ^e   Van Tol, Eric A F ^f   Tang, Qingya ^a,b,c   Cai, Wei ^b,c,d  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Shanghai Institute for Pediatric Research   (China)

^c Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition   (China)

^d XINHUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^e Mead Johnson Pediatric Nutrition Institute   (China)

^f Mead Johnson Nutritionals   (United States)

Author keywords

Bovine lactoferrin; Intestinal barrier; Short bowel syndrome

Indexed keywords

LACTOFERRIN; SECRETORY IMMUNOGLOBULIN; CLAUDIN 4; OCCLUDIN;

ANASTOMOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BACTERIAL TRANSLOCATION; BLOOD; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENTERIC FEEDING; FOOD INTAKE; INTESTINE EPITHELIUM CELL; INTESTINE FUNCTION; INTESTINE RESECTION; INTESTINE VILLUS; LIVER; MALE; MEMBRANE PERMEABILITY; MESENTERY LYMPH NODE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SHORT BOWEL SYNDROME; SPLEEN; TISSUE LEVEL; UPREGULATION; WEIGHT GAIN; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; ILEUM; INTESTINAL BARRIER; INTESTINE ANASTOMOSIS; INTESTINE CRYPT; INTESTINE MUCOSA PERMEABILITY; SMALL INTESTINE RESECTION; SPRAGUE DAWLEY RAT; WEIGHT CHANGE;

BACTERIA (MICROORGANISMS); BOVINAE; RATTUS;

ANIMALS; BACTERIAL TRANSLOCATION; CATTLE; CELL PROLIFERATION; CLAUDIN-4; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; ENTEROCYTES; GASTROINTESTINAL AGENTS; GASTROINTESTINAL CONTENTS; IMMUNOGLOBULIN A, SECRETORY; INTESTINAL MUCOSA; INTESTINE, SMALL; LACTOFERRIN; MALE; OCCLUDIN; PERMEABILITY; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SHORT BOWEL SYNDROME; WEIGHT GAIN;

EID: 84905592910     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S000711451400107X     Document Type: Article

References (30)

1. Kaufman SS, Pehlivanova M, Fennelly EM, et al. (2010) Predicting liver failure in parenteral nutrition-dependent short bowel syndrome of infancy. J Pediatr 156, 580-585.
2. Rossi L, Kadamba P, Hugosson C, et al. (2007) Pediatric short bowel syndrome: Adaptation after massive small bowel resection. J Pediatr Gastroenterol Nutr 45, 213-221.
3. Geier A, Fickert P & Trauner M (2006) Mechanisms of disease: Mechanisms and clinical implications of cholestasis in sepsis. Nat Clin Pract Gastroenterol Hepatol 3, 574-585.
4. El Kasmi KC, Anderson AL, Devereaux MW, et al. (2012) Toll-like receptor 4-dependent Kupffer cell activation and liver injury in a novel mouse model of parenteral nutrition and intestinal injury. Hepatology 55, 1518-1528.
5. Tian J, Hao L, Chandra P, et al. (2009) Dietary glutamine and oral antibiotics each improve indexes of gut barrier function in rat short bowel syndrome. Am J Physiol Gastrointest Liver Physiol 296, G348-G355.
6. Ben Lulu S, Coran AG, Mogilner JG, et al. (2010) Oral insulin stimulates intestinal epithelial cell turnover in correlation with insulin-receptor expression along the villus-crypt axis in a rat model of short bowel syndrome. Pediatr Surg Int 26, 37-44.
7. Mogilner JG, Srugo I, Lurie M, et al. (2007) Effect of probiotics on intestinal regrowth and bacterial translocation after massive small bowel resection in a rat. J Pediatr Surg 42, 1365-1371.
8. Kuhara T, Tanaka A, Yamauchi K, et al. (2014) Bovine lactoferrin ingestion protects against inflammation via IL-11 induction in the small intestine of mice with hepatitis. Br J Nutr 111, 1801-1810.
9. Kruzel ML, Harari Y, Mailman D, et al. (2002) Differential effects of prophylactic, concurrent and therapeutic lactoferrin treatment on LPS-induced inflammatory responses in mice. Clin Exp Immunol 130, 25-31.
10. Walker A (2010) Breast milk as the gold standard for protective nutrients. J Pediatr 156, Suppl. 2, S3-S7.
11. Venkatesh MP & Abrams SA (2010) Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infants. The Cochrane Database of Systematic Reviews, issue 12 CD007137.
12. Buccigrossi V, de Marco G, Bruzzese E, et al. (2007) Lactoferrin induces concentration-dependent functional modulation of intestinal proliferation and differentiation. Pediatr Res 61, 410-414.
13. Sherman MP, Bennett SH, Hwang FF, et al. (2004) Neonatal small bowel epithelia: Enhancing anti-bacterial defense with lactoferrin and Lactobacillus GG. Biometals 17, 285-289.
14. Chen J, Wen J & Cai W (2012) Smooth muscle adaptation and recovery of contractility after massive small bowel resection in rats. Exp Biol Med 237, 578-584.
15. Barnes JL, Hartmann B, Holst JJ, et al. (2012) Intestinal adaptation is stimulated by partial enteral nutrition supplemented with the prebiotic short-chain fructooligosaccharide in a neonatal intestinal failure piglet model. JPEN J Parenter Enteral Nutr 36, 524-537.
16. Wu J, Wang X, Hong L, et al. (2010) Bifidobacterium adolescentis supplementation ameliorates parenteral nutritioninduced liver injury in infant rabbits. Dig Dis Sci 55, 2814-2820.
17. Chang JX, Chen S, Ma LP, et al. (2005) Functional and morphological changes of the gut barrier during the restitution process after hemorrhagic shock. World J Gastroenterol 11, 5485-5491.
18. Fleming SC, Kapembwa MS, Laker MF, et al. (1990) Rapid and simultaneous determination of lactulose and mannitol in urine, by HPLC with pulsed amperometric detection, for use in studies of intestinal permeability. Clin Chem 36, 797-799.
19. Manzoni P, Rinaldi M, Cattani S, et al. (2009) Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: A randomized trial. JAMA 302, 1421-1428.
20. Weale AR, Edwards AG, Bailey M, et al. (2005) Intestinal adaptation after massive intestinal resection. Postgrad Med J 81, 178-184.
21. Dibaise JK, Young RJ & Vanderhoof JA (2006) Enteric microbial flora, bacterial overgrowth, and short-bowel syndrome. Clin Gastroenterol Hepatol 4, 11-20.
22. Ziegler TR, Luo M, Estívariz CF, et al. (2008) Detectable serum flagellin and lipopolysaccharide and upregulated anti-flagellin and lipopolysaccharide immunoglobulins in human short bowel syndrome. Am J Physiol Regul Integr Comp Physiol 294, R402-R410.
23. Doursout MF, Horton H, Hoang L, et al. (2013) Lactoferrin moderates LPS-induced hypotensive response and gut injury in rats. Int Immunopharmacol 15, 227-231.
24. Drago-Serrano ME, de la Garza-Amaya M, Luna JS, et al. (2012) Lactoferrin-lipopolysaccharide (LPS) binding as key to antibacterial and antiendotoxic effects. Int Immunopharmacol 12, 1-9.
25. Majerle A, Kidric. J & Jerala R (2003) Enhancement of antibacterial and lipopolysaccharide binding activities of a human lactoferrin peptide fragment by the addition of acyl chain. J Antimicrob Chemother 51, 1159-1165.
26. Hirotani Y, Ikeda K, Kato R, et al. (2008) Protective effects of lactoferrin against intestinal mucosal damage induced by lipopolysaccharide in human intestinal Caco-2 cells. Yakugaku Zasshi 128, 1363-1368.
27. Sfeir RM, Dubarry M, Boyaka PN, et al. (2004) The mode of oral bovine lactoferrin administration influences mucosal and systemic immune responses in mice. J Nutr 134, 403-409.
28. Ulluwishewa D, Anderson RC, McNabb WC, et al. (2011) Regulation of tight junction permeability by intestinal bacteria and dietary components. J Nutr 141, 769-776.
29. Hering NA, Andres S, Fromm A, et al. (2011) Transforming growth factor-b, a whey protein component, strengthens the intestinal barrier by upregulating claudin-4 in HT-29/B6 cells. J Nutr 141, 783-789.
30. Zimecki M, Artym J, Chodaczek G, et al. (2005) Effects of lactoferrin on the immune response modified by the immobilization stress. Pharmacol Rep 57, 811-817.